PRICE T ROWE ASSOCIATES INC /MD/ - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$111
+46.1%
16,537
+42.5%
0.00%
Q1 2023$76
-99.9%
11,601
-56.2%
0.00%
Q3 2022$140,000
-80.1%
26,500
-84.1%
0.00%
Q2 2022$705,000
-33.2%
166,200
-44.7%
0.00%
Q1 2022$1,055,000
-47.1%
300,574
+0.3%
0.00%
Q4 2021$1,996,000299,6740.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$12,721,0003.35%
Orbimed Advisors 8,740,887$58,214,0000.75%
Nantahala Capital Management 1,006,462$6,703,0000.24%
EcoR1 Capital, LLC 1,060,010$7,060,0000.22%
Prosight Management, LP 53,815$358,0000.21%
RA Capital Management 1,742,186$11,603,0000.20%
Endurant Capital Management LP 84,295$561,0000.14%
HighVista Strategies LLC 22,434$149,0000.12%
XTX Topco Ltd 18,816$125,0000.07%
WASATCH ADVISORS LP 1,773,690$11,813,0000.05%
View complete list of SILVERBACK THERAPEUTICS INC shareholders